CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed
Drug / intervention
paclitaxel concurrent with radiation therapydrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001442
NCT00001442Phase 1Completed
CompareCT.gov

A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer

National Cancer Institute (NCI)·interventional·Posted Nov 4, 1999·Updated Mar 4, 2008

In Brief

A Phase 1 clinical trial evaluating paclitaxel concurrent with radiation therapy for Head and Neck Neoplasm and Squamous Cell Carcinoma. Completed, across 1 site.

Detailed Summary

Radiotherapy plus Single-Agent Chemotherapy/Radiosensitization. Irradiation of tumor and involved nodes using 4-6 MV photons (brachytherapy allowed to boost primary tumor; electrons allowed to boost posterior neck and massive adenopathy); plus Paclitaxel (Bristol-Myers), Taxol, TAX, NSC-125973.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Neoplasm, Squamous Cell Carcinoma
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 4, 1999
Enrollment StartJul 1, 1995
Study CompletionJun 1, 2004
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

paclitaxel concurrent with radiation therapydrug